[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
NIMAR – The list was updated 21.12.2022

NIMAR – The list was updated 21.12.2022

by Ryan Watts | Dec 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

NIMAR – The list was updated 21.12.2022

NIMAR – The list is getting longer…

by Sally Finlayson | Nov 22, 2022 | Blog, Brexit, FMD, GDP/RP, Training

The NIMAR process is designed to ensure that people in Northern Ireland can access Prescription Only Medicines unavailable on the NI Market

Are you decommissioning products with the correct status?

Are you decommissioning products with the correct status?

by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP

The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

Do UK MA in the EU have to Serialise the packs for the UK Market when GB does require the packs to be serialised?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

he UK MAs currently cover the whole of the “UK” so the UK MAs include Northern Ireland Supply…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in GB need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

Lets start with the definition GB is now only…

The “Safety features” element of EUFMD (FMD2011/62/EU) and Delegated Regulation (20016/161) What Pharmacies in Northern Ireland (NI) need to know and do?

by Jackie (née Heneghan) Peck | Jan 14, 2021 | Blog, FMD

For Northern Irish Pharmacies FMD requirements have not changed and they must continue to verify and decommission their “2D” barcoded packs…

« Older Entries

Recent Posts

  • What are the main requirements for controlled drugs?
  • FSN for Zoll Powerheart G5 AEDs
  • Virtual Wholesaling

Upcoming Courses

  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025
  • GDP Audit Online Training on 17 July 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 23 July 2025 10:00 am
  • Export Online Training on 7 August 2025

MHRA Alerts & Recalls

Field Safety Notices: 9 to 13 June 2025
17 June 2025
MHRA Safety Roundup: May 2025
13 June 2025
Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection, Maxearn Limited, EL(25)A/27
12 June 2025
Class 4 Medicines Defect Notification: Dulcolax Adult 5 mg Gastro-resistant Tablets, Opella Healthcare UK, EL(25)A/26
10 June 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow